{
    "applicationNumber": "BR 11 2021 017678-0",
    "filingDate": "06/03/2020",
    "grantDate": null,
    "title": "USO DE CATEQUENTINIBE (ANLOTINIBE) COMBINANDO COM QUIMIOTERAPIA PADR\u00c3O OU IMUNOTERAPIA EM ORDEM SEQUENCIAL PARA O TRATAMENTO DE C\u00c2NCER",
    "nationalPhaseDate": [
        "06/09/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/021457",
        "pctDate": "06/03/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/815,266",
            "priorityDate": "07/03/2019"
        },
        {
            "countryCode": "US",
            "priorityNumber": "62/876,181",
            "priorityDate": "19/07/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2645"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2654"
        }
    ],
    "inventors": [
        "CHEN GUOQING PAUL",
        "CHEN JUDY",
        "LI ZHE",
        "LI YINGYIN"
    ],
    "holders": [
        199512,
        110007
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 31/4709"
    ]
}